166 related articles for article (PubMed ID: 38647314)
1. Polycatechols inhibit ferroptosis and modulate tau liquid-liquid phase separation to mitigate Alzheimer's disease.
Moorthy H; Ramesh M; Padhi D; Baruah P; Govindaraju T
Mater Horiz; 2024 Jul; 11(13):3082-3089. PubMed ID: 38647314
[TBL] [Abstract][Full Text] [Related]
2. Hybrid molecules synergistically mitigate ferroptosis and amyloid-associated toxicities in Alzheimer's disease.
Padhi D; Baruah P; Ramesh M; Moorthy H; Govindaraju T
Redox Biol; 2024 May; 71():103119. PubMed ID: 38507972
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.
Derry PJ; Hegde ML; Jackson GR; Kayed R; Tour JM; Tsai AL; Kent TA
Prog Neurobiol; 2020 Jan; 184():101716. PubMed ID: 31604111
[TBL] [Abstract][Full Text] [Related]
4. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation.
Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ
Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024
[TBL] [Abstract][Full Text] [Related]
5. Liquid-liquid phase separation in Alzheimer's disease.
Fu Q; Zhang B; Chen X; Chu L
J Mol Med (Berl); 2024 Feb; 102(2):167-181. PubMed ID: 38167731
[TBL] [Abstract][Full Text] [Related]
6. The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review.
Wang X; Li H; Sheng Y; He B; Liu Z; Li W; Yu S; Wang J; Zhang Y; Chen J; Qin L; Meng X
Biomed Pharmacother; 2024 Feb; 171():116071. PubMed ID: 38183741
[TBL] [Abstract][Full Text] [Related]
7. Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.
Li M; Fan Y; Li Q; Wang X; Zhao L; Zhu M
Oxid Med Cell Longev; 2022; 2022():7165387. PubMed ID: 36246407
[TBL] [Abstract][Full Text] [Related]
8. LINC00472 Regulates Ferroptosis of Neurons in Alzheimer's Disease via FOXO1.
Lin P; Wang J; Li Y; Li G; Wang Y
Dement Geriatr Cogn Disord; 2024; 53(3):107-118. PubMed ID: 38574473
[TBL] [Abstract][Full Text] [Related]
9. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Tau Condensates by Liquid-Liquid Phase Separation to Study Tau Amyloid Aggregation.
Lin Y
Methods Mol Biol; 2024; 2754():185-192. PubMed ID: 38512667
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis: a potential therapeutic target for Alzheimer's disease.
Yang L; Nao J
Rev Neurosci; 2023 Jul; 34(5):573-598. PubMed ID: 36514247
[TBL] [Abstract][Full Text] [Related]
12. Cyclic dipeptide-based small molecules modulate zinc-mediated liquid-liquid phase separation of tau.
Ramesh M; Balachandra C; Baruah P; Govindaraju T
J Pept Sci; 2023 May; 29(5):e3465. PubMed ID: 36471564
[TBL] [Abstract][Full Text] [Related]
13. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
14. Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimer's disease.
Yong YY; Yan L; Wang BD; Fan DS; Guo MS; Yu L; Wu JM; Qin DL; Law BY; Wong VK; Yu CL; Zhou XG; Wu AG
Phytomedicine; 2024 May; 127():155463. PubMed ID: 38452694
[TBL] [Abstract][Full Text] [Related]
15. Myricetin slows liquid-liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity.
Dai B; Zhong T; Chen ZX; Chen W; Zhang N; Liu XL; Wang LQ; Chen J; Liang Y
J Biol Chem; 2021 Oct; 297(4):101222. PubMed ID: 34560101
[TBL] [Abstract][Full Text] [Related]
16. Iron and Targeted Iron Therapy in Alzheimer's Disease.
Wang J; Fu J; Zhao Y; Liu Q; Yan X; Su J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003544
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis.
Gao Y; Li J; Wu Q; Wang S; Yang S; Li X; Chen N; Li L; Zhang L
Int Immunopharmacol; 2021 Oct; 99():108002. PubMed ID: 34333354
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
19. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
20. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
